Literature DB >> 2358559

European attitudes towards ethical problems in intensive care medicine: results of an ethical questionnaire.

J L Vincent1.   

Abstract

A questionnaire was sent to the 590 members of the European Society of Intensive Care Medicine to define both the current practices and the opinions of these specialists on various ethical issues. The answers from 242 (41%) European members were collected and analysed. The first part of the questionnaire was designed to define the criteria for admission to Intensive Care throughout Europe. Admissions to the ICU were generally or commonly limited by the number of available beds according to 57% of the respondents and sometimes or almost never according to 41% (100/242). Bed availability in the ICU was especially limited in Spain, Portugal, Italy and the United Kingdom. Despite limited bed availability, two thirds of the respondents did admit patients who were thought to have little or no hope of survival other than for a few weeks. When asked about what ought to be done in these circumstances, the number of respondents who supported the admission of such terminal patients to ICU was halved. These data illustrate the heterogeneity of admission practices in Europe and stress the need for all ICUs to define a policy for admission. The second part was designed to assess the information given to patients in the ICU. Only 24 (10%) of the respondents stated that they always delivered complete information to their patients and only 31 (13%) thought they should do so. When an iatrogenic incident occurred, only 39 (16%) claimed to relate exactly what had happened, to the patient or their relatives but 121 (50%) thought they should. Informed consent was usually required for surgery or gastroscopy and the administration of a new medication.

Entities:  

Keywords:  Empirical Approach; European Society of Intensive Care Medicine; Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1990        PMID: 2358559     DOI: 10.1007/bf01705162

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  38 in total

Review 1.  Initiating and withdrawing life support. Principles and practice in adult medicine.

Authors:  J E Ruark; T A Raffin
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

2.  Recommendations for intensive care unit admission and discharge criteria. Task Force on Guidelines. Society of Critical Care Medicine.

Authors: 
Journal:  Crit Care Med       Date:  1988-08       Impact factor: 7.598

3.  The euthanasia debate.

Authors:  D Brahams
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

4.  Do we need informed consent?

Authors:  M Baum
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

5.  Survival of intensive care patients. I: Prognostic factors from the patient's medical history.

Authors:  B Zarén; R Bergström
Journal:  Acta Anaesthesiol Scand       Date:  1988-02       Impact factor: 2.105

6.  Do patients want to be informed? A study of consent for cardiac catheterisation.

Authors:  A G Fraser
Journal:  Br Heart J       Date:  1984-10

7.  Survival, hospitalization charges and follow-up results in critically ill patients.

Authors:  D J Cullen; L C Ferrara; B A Briggs; P F Walker; J Gilbert
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

8.  Terminal events in the intensive care unit: review of 258 fatal cases in one year.

Authors:  J L Vincent; J N Parquier; J C Preiser; S Brimioulle; R J Kahn
Journal:  Crit Care Med       Date:  1989-06       Impact factor: 7.598

9.  Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit.

Authors:  H N Reynolds; M T Haupt; M C Thill-Baharozian; R W Carlson
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

10.  Artificial feeding--solid ground, not a slippery slope.

Authors:  R Steinbrook; B Lo
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

View more
  36 in total

1.  'End-of-life' decision making within intensive care--objective, consistent, defensible?

Authors:  A J Ravenscroft; M D Bell
Journal:  J Med Ethics       Date:  2000-12       Impact factor: 2.903

2.  Factors affecting physicians' decisions to forgo life-sustaining treatments in terminal care.

Authors:  H Hinkka; E Kosunen; R Metsänoja; U-K Lammi; P Kellokumpu-Lehtinen
Journal:  J Med Ethics       Date:  2002-04       Impact factor: 2.903

Review 3.  [Ethics in intensive medicine].

Authors:  W F List
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

4.  Medical decision-making: an argument for narrative and metaphor.

Authors:  Katherine Hall
Journal:  Theor Med Bioeth       Date:  2002

5.  Impact of an intensive communication strategy on end-of-life practices in the intensive care unit.

Authors:  J P Quenot; J P Rigaud; S Prin; S Barbar; A Pavon; M Hamet; N Jacquiot; B Blettery; C Hervé; P E Charles; G Moutel
Journal:  Intensive Care Med       Date:  2011-11-30       Impact factor: 17.440

6.  Ethical problems in intensive care medicine and case reporting.

Authors:  D P Coates
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Euthanasia.

Authors:  J C Vincent
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

8.  A profile of European ICU nursing.

Authors:  B Depasse; D Pauwels; Y Somers; J L Vincent
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

9.  End-of-life attitudes of intensive care physicians in Poland: results of a national survey.

Authors:  Andrzej Kübler; Barbara Adamik; Malgorzata Lipinska-Gediga; Jaroslaw Kedziora; Lukasz Strozecki
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

10.  Should cancer patients be informed about their diagnosis and prognosis? Future doctors and lawyers differ.

Authors:  Bernice S Elger; T W Harding
Journal:  J Med Ethics       Date:  2002-08       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.